After a long struggle with the Anglo-Swedish pharmaceutical firm AstraZeneca, European Union leaders have agreed against banning vaccine exports.
They gave their support in principle to tightening export controls at a summit on Thursday.
However, a statement issued after the summit stressed the role of global supply chains in the manufacture of vaccines.
AstraZeneca vaccine components are produced in a variety of EU countries.
AstraZeneca must “catch up” on deliveries to the EU, according to European Commission President Ursula von der Leyen, before exporting doses elsewhere.
The EU’s “naivety” has come to an end, according to French President Emmanuel Macron.
By the end of March, the EU expects to receive about 30 million AstraZeneca doses, less than a third of what it had hoped for.